Abstract
Deep-learning workflows of microscopic image analysis are sufficient for handling the contextual variations because they employ biological samples and have numerous tasks. The use of well-defined annotated images is important for the workflow. Cancer stem cells (CSCs) are identified by specific cell markers. These CSCs were extensively characterized by the stem cell (SC)-like gene expression and proliferation mechanisms for the development of tumors. In contrast, the morphological characterization remains elusive. This study aims to investigate the segmentation of CSCs in phase contrast imaging using conditional generative adversarial networks (CGAN). Artificial intelligence (AI) was trained using fluorescence images of the Nanog-Green fluorescence protein, the expression of which was maintained in CSCs, and the phase contrast images. The AI model segmented the CSC region in the phase contrast image of the CSC cultures and tumor model. By selecting images for training, several values for measuring segmentation quality increased. Moreover, nucleus fluorescence overlaid-phase contrast was effective for increasing the values. We show the possibility of mapping CSC morphology to the condition of undifferentiation using deep-learning CGAN workflows.
Highlights
Tumors are believed to be maintained by a minor population of cancer cells
The Artificial intelligence (AI) was expected to learn the morphology of Mouse iPS (miPS)-LLCcm cells shown on phase contrast cell images in relation to the corresponding green fluorescent protein (GFP) fluorescence
We examined both the training and procurement of the AI that predicts GFP fluorescence positive miPS-LLCcm cells in phase contrast cell images without GFP fluorescence image information
Summary
Tumors are believed to be maintained by a minor population of cancer cells. These are termed cancer stem cells (CSCs) to describe the extraordinary characteristics of these cells provoking new tumors as determined by an allograft mouse tumor system [1]. The CSCs have the ability to grow themselves while maintaining an undifferentiated property and to generate progenitor cells with the potential to produce a major population of cancer cells. The first evidence of CSCs was reported in a study of blood tumor-initiating cells showing the hematopoietic stem cell (SC) surface marker, cluster of differentiation (CD), CD34+/CD38. The cell-surface markers characteristic to CSCs were identified to separate them from other cells. CD24−/low/CD44+, CD20+ in spheroid cells, and CD133+
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.